Quote:
Originally Posted by billethkid
I don't know the answer in fact, however, I would bet it has to do with the rate of pillage, rape and plunder of a patient is allowed.
We know that here in the USA pharmaceuticals companies welfare come way way WAY before the patient.
Good example: $700 per month cancer med comes through Canad for $119 shipped to the door for a generic. The generic and the name brand are both made here in the USA....the US patents allow the maker to keep generics off the market for a too long period of time. And I for one do not accept the notion they are recovering their investment....not when the companies continue to apply for extensions and get them. And the companies earnings are continuing to SPIRAL upward.
|
Don't get me started on cancer drugs. Oncology practices make roughly 40% to 80% dispensing drugs. Here's some prices that will show the difference in prices here in the good ole USA
Temodar/Xeloda - $5451.80 at Publix of which I paid $1126.77, $2797.48 at CVS/Caremark
Afinitor - $9331.23 at CVS/Caremark; Sandosatin LAR (injectable) $8070.00 at oncology practice, $4059.19 delivered to practice from CVS/Caremark. Thank GOD we don't pay those prices but they are charged to the insurance company! All those drugs are only a 28 day supply. I don't know what they would cost in Canada, but I have to find out.